$AMGN
Amgen Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is AMGN down today? It is at $406.37 (-0.36%), and our scanner flagged it 43 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AMGN spikes, and full due diligence on AMGN — key stats, earnings, dilution and insider activity. Free.
Get free $AMGN alerts the moment volume spikes
Our scanner flagged $AMGN 43 times in the last 30 days. Create a free account to track $AMGN, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $406.37
- Change today
- -0.36%
- Previous close
- $407.83
- 52-week range
- $269.77 – $416.24
- Market cap
- $220.49B
- P/E ratio
- 28.99
- Dividend yield
- 2.47% ($10.08)
- Institutional own.
- 93.37%
- Total held
- 93.9%
- Tradeable float
- 33.1M 6% of shares · after <1% insiders + 93% institutions
- Short interest
- 12.8M ▼ -0% vs prior · as of 2026-07-15
- Short % of float
- 38.8%
- Days to cover
- 6.4d
- Avg daily volume
- 2.7M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.3x
- 15m
- 0.4x
- 1hthin
- 0.6x
- 1D
- 0.0x
Get free AMGN + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $AMGN moving today?
AMGN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on AMGN today, peaking at 10.0x its normal volume. A recent catalyst in the news: “State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?.”
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Insiders
Insiders buying11 buys, 0 sells last 3 months (41/55 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Austin Wanda M Director | Acquired (grant/award) | +665 | added 9.0% | 8K | n/a | May 19, 26 |
Drake Michael V Director | Acquired (grant/award) | +665 | added 13% | 6K | n/a | May 19, 26 |
Druker Brian Director | Acquired (grant/award) | +665 | added 8.6% | 8K | n/a | May 19, 26 |
Eckert Robert Director | Acquired (grant/award) | +665 | added 2.6% | 26K | n/a | May 19, 26 |
Garland Greg C. Director | Acquired (grant/award) | +665 | added 5.0% | 14K | n/a | May 19, 26 |
Holley Charles M Director | Acquired (grant/award) | +665 | added 5.5% | 13K | n/a | May 19, 26 |
Ishrak Omar Director | Acquired (grant/award) | +665 | added 9.9% | 7K | n/a | May 19, 26 |
Jacks Tyler Director | Acquired (grant/award) | +665 | added 3.8% | 18K | n/a | May 19, 26 |
Klotman Mary E. Director | Acquired (grant/award) | +665 | added 43% | 2K | n/a | May 19, 26 |
Kullman Ellen Jamison Director | Acquired (grant/award) | +665 | added 4.8% | 15K | n/a | May 19, 26 |
Miles Amy E Director | Acquired (grant/award) | +665 | added 13% | 6K | n/a | May 19, 26 |
Bradner James E. Officer | Sold (automatic/other) | -446 | sold 1.5% | 30K | $148K at $331.11 | May 7, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $AMGN runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$AMGN Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$AMGN Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to AMGN
Comparable names in biological products, (no diagnostic substances), closest in size first.
AMGN is in these themes
Curated groups AMGN belongs to. Tap one to see every member with today's move and why the group is moving.
AMGN stock FAQ
Why is $AMGN moving today?
AMGN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on AMGN today, peaking at 10.0x its normal volume. A recent catalyst in the news: “State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?.”
What is the AMGN stock price today?
AMGN last traded at $406.37, down 0.36% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Does AMGN pay a dividend?
Yes. AMGN currently has a dividend yield of about 2.47% ($10.08 per share per year). Dividend figures can change; this is not investment advice.
Where can I see live AMGN alerts?
The AMGN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AMGN 43 times in the last 30 days.
What exchange is AMGN on?
AMGN (Amgen Inc) trades on XNAS, with a market cap of about $220.49B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is AMGN good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AMGN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.